Cabozantinib

A Phase II Study of Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

Arms / Cohorts

Group A:RET Fusion

Accepting patients

Group B:NTRK Fusion OR MET or AXL

Accepting patients

Group C:ROS1 Fusion

Accepting patients

Group D:RET Fusion with Progression on RET TKI

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(831) 888-0898

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.